The ubiquitin-like protein BAG-6 protects cells from newly synthesized misfolded proteins by tethering them to the proteasome.

The short-term outcomes in this series provide further evidence that RALS may be superior to CLS for rectal cancer.

Our data suggested three phases of the learning curve in robotic-assisted surgery for rectal cancer. The first 25 cases formed the learning phase.

Mesorectal fat area may serve as a useful predictor of the difficulty of total mesorectal excision for rectal cancer.

The short-term outcomes of RALLD may be superior to those of OLLD for advanced lower rectal cancer.

The present study demonstrated that RALS has some advantages in terms of surgical outcomes over CLS in challenging situations of rectal cancer surgery, such as lower rectal cancer cases and visceral obesity cases.

No abstract

Robotic-assisted lateral lymph node dissection is a safe, feasible, and useful approach for patients with advanced lower rectal cancer.